Latest Dividend News

2 Cheap Cars Group maintained steady revenue and profit in FY26 despite softer vehicle sales and regulatory headwinds, driven by strong EV demand and record finance and insurance penetration.

Turners Automotive Group posted a record $63.2 million normalised NPBT for FY26, beating guidance and declaring a 14% higher dividend as it accelerates branch expansion and ecosystem integration.

Ashley Services Group is set to acquire major logistics labour hire contracts generating $162 million in annual revenue, with the deal expected to enhance earnings per share in FY27.

SunRice reported a 4% rise in net profit after tax for FY26 to $73.3 million, maintaining an 8% EBITDA margin despite a 2.5% revenue decline. The company declared a record fully franked dividend of 70 cents per share but expects FY27 profit to fall amid a smaller Australian rice crop.

GTN Limited projects a sharp fall in FY26 earnings amid tough market conditions but signals a hefty dividend and a rebound in FY27 EBITDA.

Goodman NZ (NZX:GNZ) posted a 126% jump in statutory profit to $248 million for FY26, underpinned by strong property revaluations and leasing gains. The group completed its corporatisation and stapling, launched a property funds management platform, and progressed a development pipeline exceeding $1 billion.

Bankers Investment Trust reported a 3.7% NAV total return for the half-year to April 2026, outpacing the FTSE World Index, while declaring a 3.1% dividend increase. Fund manager Alex Crooke announced retirement, with Richard Clode set to take the helm.

The a2 Milk Company has announced a $300 million fully franked special dividend following regulatory clearance in China to rebrand infant formula products under its a2 label.

ALS Limited has updated its Dividend Reinvestment Plan price to AUD 22.93 and confirmed the share allocation date as 3 July 2026 for its interim dividend covering the six months to March 2026.

Transurban Group (ASX: TCL) declared a 35-cent unfranked distribution per stapled security for the six months ending 30 June 2026, payable in August with no approvals required.

Kingfish Limited posted a $13.6 million net loss for the year ended 31 March 2026, with portfolio returns lagging the benchmark amid geopolitical tensions and AI sector uncertainty.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.